Kidney disease has been linked to dysregulated signaling via PKC in kidney cells such as podocytes. PKCα is a conventional
isoform of PKC and a well-known binding partner of β-
catenin, which promotes its degradation. β-
Catenin is the main effector of the canonical Wnt pathway and is critical in cell adhesion. However, whether other PKC
isoforms interact with β-
catenin has not been studied systematically. Here we demonstrate that PKCϵ-deficient mice, which develop
proteinuria and glomerulosclerosis, display lower β-
catenin expression compared with PKC wild-type mice, consistent with an altered phenotype of podocytes in culture. Remarkably, β-
catenin showed a reversed subcellular localization pattern: Although β-
catenin exhibited a perinuclear pattern in undifferentiated wild-type cells, it predominantly localized to the nucleus in PKCϵ knockout cells.
Phorbol 12-myristate 13-acetate stimulation of both cell types revealed that PKCϵ positively regulates β-
catenin expression and stabilization in a
glycogen synthase kinase 3β-independent manner. Further, β-
catenin overexpression in PKCϵ-deficient podocytes could restore the wild-type phenotype, similar to rescue with a PKCϵ construct. This effect was mediated by up-regulation of
P-cadherin and the β-
catenin downstream target fascin1. Zebrafish studies indicated three PKCϵ-specific phosphorylation sites in β-
catenin that are required for full β-
catenin function. Co-immunoprecipitation and pulldown assays confirmed PKCϵ and β-
catenin as binding partners and revealed that ablation of the three PKCϵ phosphorylation sites weakens their interaction. In summary, we identified a novel pathway for regulation of β-
catenin levels and define PKCϵ as an important β-
catenin interaction partner and signaling opponent of other PKC
isoforms in podocytes.